Segments - Veterinary Infectious Disease Diagnostics Market by Technology (Molecular Diagnostics, Immunodiagnostics, and Others), Animal (Food-producingand Companion), Infection Type (Viral, Parasitic, Bacterial, and Others),End-user (Reference Labs, Hospitals, Point of Care/In House Testing, Clinics, and Universities),and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size,Trends, and Forecast 2023 – 2031
The global veterinary infectious disease diagnostics market size was USD 1.46 Bn in 2022 and is likely to reach USD 3.4 Bn by 2031, expanding at a CAGR of 9.9% during 2023–2031. The market growth is attributed to the rising innovative diagnostic technologies and growing emphasis on preventive healthcare for animals.
Rising awareness of animal health is anticipated to boost the veterinary infectious disease diagnostics market in the coming years. Growing technological advancements such as molecular diagnostics and point-of-care testing lead to improving the effectiveness of disease detection and management.
Veterinary infectious disease diagnostics includes a range of tests designed to identify various illnesses in animals. These examinations utilize samples such as tissue, excrement, and blood from the patients. Additionally, advancements in technology and techniques developed for human medicine are often adapted for use in veterinary infectious disease diagnostics. The timely and accurate diagnosis of infectious diseases in animals is essential for effective treatment and control measures, which is ultimately protect both animal and human health.
The market report finds that the COVID-19 pandemic boosted theveterinary infectious disease diagnostics market.The pandemic increased awareness about infectious diseases, prevalent not only in humans but also in animals. This increased awareness led to a surge in the demand for veterinary infectious disease diagnostics, as pet owners and professionals in the animal health industry seek to monitor and manage the health of animals closely.
Increasing pet ownershipdrives the market. More individuals are owning pets,which means that a large population of animals are inneed of healthcare services,including diagnostic testing for infectious diseases.Nowadays pet owners are increasingly conscious of the health and well-being of their pets. They are inclined to invest in regular health check-ups to provide healthy lives to their pets.This creates a substantial demand for veterinary diagnostic services and products.
Rising cost of pet care hampers the veterinary infectious disease diagnostics market. The rising costs of pet care deter some pet owners from investing in regular check-ups and preventive healthcare, including diagnostic testing. This results in a missed opportunity for early disease detection and management.
Increasing prevalence of transboundary and zoonotic diseases creates lucrative opportunities for the market. The rising transboundary and zoonotic diseases necessitate efficient diagnostic tools to promptly identify and manage these diseases in animals. The international spread of diseases such as rabies, avian influenza, and others highlights the need for robust diagnostic capabilities, especially in regions with high incidence rates. For instance,
In September 2023, the World Health Organization (WHO) reported rabies cases in over 150 nations and territories. Dogs are identified as the primary source of human rabies fatalities, contributing to up to 99% of rabiestransmissions.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Veterinary Infectious Disease Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Technology (Molecular Diagnostics, Immunodiagnostics, and Others), Animal (Food-producing and Companion),Infection Type (Viral, Parasitic, Bacterial, and Others), andEnd-user (Reference Labs, Hospitals, Point of Care/In House Testing, Clinics, and Universities) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, MarketTrends, and Revenue Forecast |
Key Players Covered in the Report |
Boehringer Ingelheim International GmbH; Heska Corporation; IDEXX Laboratories Inc.; Indical Bioscience GmbH; Neogen Corporation; Randox Laboratories Ltd.; Thermo Fisher Scientific Inc.; Virbac; and Zoetis Services LLC. |
Based on technology, the veterinary infectious disease diagnostics market is divided into molecular diagnostics, immuno diagnostics, and others. The immuno diagnostics segment is expected to hold a dominant share of the market during the projection period, due tothe rising demand for early disease detection and analysis.
Immuno diagnostic methods such as enzyme-linked immuno sorbent assay (ELISA), lateral flow assays, and immuno fluorescence assays are known for their high sensitivity and specificity in detecting specific antibodies or antigens associated with infectious agents. This ensures accurate and reliable results, which are crucial in diagnosing infectious diseases in animals.This encourages manufacturers to develop veterinary products to provide quality diagnosis for animals. For instance,
In April 2021, INDICAL, a global leader in developing complete solutions for immunological and molecular veterinary testing, acquired the Svanova product portfolio from Boehringer Ingelheim. Itsaim is to exclusively provide a veterinary testing product by Svanova.
The molecular diagnostics segmentis expected to expand at a significant growth rate in the coming years, due tothe ability to detect low pathogen levels and identification of genetic variants.Molecular diagnostics are capable of detecting even very low levels of pathogens, making them invaluable for early detection of infections and monitoring of disease progression.
Molecular techniques identify specific genetic variants and strains of pathogens, which is crucial for epidemiological studies, tracking disease outbreaks, and implementing targeted control measures.
On the basis of animal, the global market is bifurcated into food-producing and companion. The companion segment is projected to register a high CAGR during the forecast period,due to the increasing the number of pet ownership and rising awareness among individuals for pet care.
A rising number of individuals own companion animals,including dogs, cats, and other small pets. Increasing pet ownership directly translates to a high demand for veterinary services,including infectious disease diagnostics. Pet owners are increasing becoming well nformed and attentive to the health of their animal companions. They are increasingly inclined to invest in regular health check-ups, including diagnostic tests, to ensure the longevity and quality of life for their pets.
The food-producing segment is expected to expand at a significant growth rate in the coming years,due toincreasing meat consumption and rising preventative measures for food safety. The global population is steadily growing, which leads to a corresponding increase in the demand for meat and other animal products.
This rising consumption necessitates effective infectious disease diagnostics to ensure the health and safety of food-producing animals. Effective diagnostics help identify and control infectious agents that are transmitted to humans through the consumption of contaminated animal products.
On the basis of infection type, the veterinary infectious disease diagnostics market is segmented into viral, parasitic, bacterial, and others. The viral segment is anticipated to register a robust growth rate during the forecast period,due to the rising prevalence of viral infection and developing viral outbreaks.
Viral infections are widespread among animals, which makes them a primary concern for veterinary diagnostics. The need for accurate and timely detection of these infections is crucial for effective disease management.The occurrence of novel viral outbreaks, as observed with diseases such as West Nile virus, avian influenza, and others,highlights the urgency in diagnosing viral infections. This drives the demand for advanced diagnostic tools.
Based on end-user, the veterinary infectious disease diagnostics market is divided into reference laboratories hospitals, point of care/in house testing, clinics, and universities. The reference laboratories segment is expected to generate a major revenue share of the market,due to the availability of specialized expertise and equipment.
Reference laboratories are equipped with advanced diagnostic technologies and are staffed with highly trained technicians and pathologists specializing in veterinary diagnostics. Reference laboratories typically offer a wide range of diagnostic tests for various infectious diseases in animals, covering a spectrum of pathogens including viruses, bacteria, and parasites.This ensures a high level of accuracy and reliability in test results.
The veterinary clinic segment is projected to expand at a considerable growth rate during the projection period, due to it being a primary pet healthcare facility witheasy accessibility & convenience to pet owners.Clinics serve as the primary healthcare providers for animals. They are widely accessible to pet owners in both urban and rural areas. This accessibility makes clinics a primary point of contact for pet owners who seek diagnostic services such as routine check-ups, vaccinations, and diagnostics for their animals.
In terms of region, the global veterinary infectious disease diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, due to advanced healthcare infra structure and the presence of high pet ownership.
North America is recognized forits highly developed and sophisticated healthcare infrastructure, including veterinary care. The region is home to various advanced veterinary clinics, hospitals, and diagnostic laboratories equipped with cutting-edge technology and equipment. North America, particularly the US, has a significant population of companion animals,including dogs, cats, and small mammals. This large pet population drives the demand for veterinary services, including diagnostics.
The market in Asia Pacific is projected to expand rapidly during the forecast period, owing to the growing awareness of animal health and the rising prevalence of zoonotic disease.The rising awareness of the importance of proper animal healthcare in AsiaPacific leads to pet owners becoming increasingly conscious of preventive measures to ensure the well-being of their animals. AsiaPacific has experienced outbreaks of zoonotic diseases, which has led to an increased focus on veterinary diagnostics for early detection of diseases such as avian influenza and rabies.
The veterinary infectious disease diagnosticsmarket has been segmented on the basis of
Key players competing in the global veterinary infectious disease diagnostics market are Boehringer Ingelheim International GmbH; Heska Corporation; IDEXX Laboratories Inc.; Indical Bioscience GmbH; Neogen Corporation; Randox Laboratories Ltd.; Thermo Fisher Scientific Inc.; Virbac; and Zoetis Services LLC.
These companies adopted development strategies, including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion, to expand their consumer base globally. For instance,
In July 2022, Boehringer Ingelheim announced a collaborative venture with Evotec and bioMérieux, aimed at developing advanced antimicrobial solutions coupled with effective diagnostics to combat the growing challenge of Antimicrobial Resistance (AMR).